Home » Black executive Kenneth Frazier loses $6.4 million from Merck & Co. stake

Black executive Kenneth Frazier loses $6.4 million from Merck & Co. stake

Black executive Kenneth Frazier's Merck stake dips

by Feyisayo Ajayi
Kenneth Frazier

Kenneth Frazier, the first Black executive to lead a major pharmaceutical company, has seen the market value of his stake in Merck & Co. decline by millions of dollars following a recent plunge in the share price of the American multinational pharmaceutical company.

According to market data, Frazier, the former executive chairman and CEO of Merck & Co., has seen his stake in the New Jersey-based pharmaceutical giant slump by $6.42 million over the last three weeks, reflecting the recent decline in the company’s share price.

Merck shares slump seven percent as market cap dips below $310 billion

Merck & Co., a leading healthcare company, has solidified its place in the industry by offering a range of healthcare solutions, including prescription drugs, vaccines, biological therapies, animal health products, and consumer healthcare products. The company operates across three segments: pharmaceutical, animal health, and other.

The company’s shares on the New York Stock Exchange have seen a recent decline of 7.04 percent, falling from $129.45 on Feb. 23 to $120.34 at the time of this report. As a result, the company’s market capitalization has fallen below $310 billion, leading to significant losses for shareholders, including Frazier.

Black executive Kenneth Frazier’s Merck stake dips

Kenneth Frazier, a prominent Black executive in the U.S., holds a 0.028-percent stake in Merck & Co., currently valued at $84.9 million. Frazier’s total compensation from the pharmaceutical giant in 2022 declined 78.6 percent to $8.5 million, down from $15.2 million the prior year. 

According to data tracked by Billionaires.Africa shows the market value of Frazier’s Merck stake has fallen by $6.42 million, slipping from $91.29 million on Feb. 23 to $84.87 million at the time of this report.

Despite the recent decline, Frazier remains a top Black executive, recognized for his strategic leadership and Merck’s commitment to innovation and sustainable healthcare solutions, which continue to attract investors.

You may also like


The world’s premier source of news on Africa’s billionaires and UHNWIs.


Get the daily email to stay informed about African billionaires and UHNWIs. Get informed and entertained, for free.

Latest News

@2024 – Billionaires.Africa. All Rights Reserved.